Literature DB >> 16983830

Template-driven gene selection procedure.

N Knowlton1, I Dozmorov, K D Kyker, R Saban, C Cadwell, M B Centola, R E Hurst.   

Abstract

The hierarchical clustering and statistical techniques usually used to analyse microarray data do not inherently represent the underlying biology. Herein, a hybrid approach involving characteristics of both supervised and unsupervised learning is presented. This approach is based on template matching in which the interaction of the variables of inherent malignancy and the ability to express the malignant phenotype are modelled. Immortalised normal urothelial cells and bladder cancer cells of different malignancy were grown in conventional two-dimensional tissue culture and in three dimensions on extracellular matrices (ECMs) that were either permissive or restrictive for expression of the malignant phenotype. The transcriptome represents the effects of two variables--inherent malignancy and the modulatory effect of ECM. By assigning values to each of the biological variables of inherent malignancy and the ability to express the malignant phenotype, a template was constructed, which encapsulated the interaction between them. Gene expression correlating both positively and negatively with the template was observed, but when iterative correlations were carried out, the different models for the template converged on the same actual template. A subset of 21 genes was identified, which correlated with two a priori models or an optimised model above the 95% confidence limits identified in a bootstrap resampling with 5000 permutations of the data set. The correlation coefficients of expression of several genes were > 0.8. Analysis of upstream transcriptional regulatory elements (TREs) confirmed that these genes were not a randomly selected set of genes. Several TREs were identified as significantly over-expressed in the sample of 20 genes for which TREs were identified, and the high correlations of several genes were consistent with transcriptional co-regulation. The authors suggest that the template method can be used to identify a unique set of genes for further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983830      PMCID: PMC1618795          DOI: 10.1049/ip-syb:20050020

Source DB:  PubMed          Journal:  Syst Biol (Stevenage)        ISSN: 1741-2471


  33 in total

1.  Evaluation of gene expression measurements from commercial microarray platforms.

Authors:  Paul K Tan; Thomas J Downey; Edward L Spitznagel; Pin Xu; Dadin Fu; Dimiter S Dimitrov; Richard A Lempicki; Bruce M Raaka; Margaret C Cam
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

2.  Outcome signature genes in breast cancer: is there a unique set?

Authors:  Liat Ein-Dor; Itai Kela; Gad Getz; David Givol; Eytan Domany
Journal:  Bioinformatics       Date:  2004-08-12       Impact factor: 6.937

3.  Hypervariable genes--experimental error or hidden dynamics.

Authors:  Igor Dozmorov; Nicholas Knowlton; Yuhong Tang; Alan Shields; Parima Pathipvanich; James N Jarvis; Michael Centola
Journal:  Nucleic Acids Res       Date:  2004-10-28       Impact factor: 16.971

4.  Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.

Authors:  C Cordon-Cardo; Z Fuks; M Drobnjak; C Moreno; L Eisenbach; M Feldman
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

Review 5.  Analytical molecular pathology of epithelial-stromal interactions in the normal and neoplastic prostate.

Authors:  H Bonkhoff
Journal:  Anal Quant Cytol Histol       Date:  1998-10       Impact factor: 0.302

6.  Interleukin-1B: a clinically relevant urinary marker.

Authors:  S M Martins; D J Darlin; P M Lad; P E Zimmern
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

7.  Functional role of death-associated protein 3 (DAP3) in anoikis.

Authors:  Tadaaki Miyazaki; Min Shen; Daisuke Fujikura; Noriko Tosa; Hyung-Ryong Kim; Shigeyuki Kon; Toshimitsu Uede; John C Reed
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

8.  Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment.

Authors:  Angelica Loskog; Helena Dzojic; Sofia Vikman; Christina Ninalga; Magnus Essand; Olle Korsgren; Thomas H Totterman
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

9.  Linking disease-associated genes to regulatory networks via promoter organization.

Authors:  S Döhr; A Klingenhoff; H Maier; M Hrabé de Angelis; T Werner; R Schneider
Journal:  Nucleic Acids Res       Date:  2005-02-08       Impact factor: 16.971

10.  A cell line from an anaplastic transitional cell carcinoma of human urinary bladder.

Authors:  S K Nayak; C O'Toole; Z H Price
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

View more
  2 in total

1.  Internal standard-based analysis of microarray data2--analysis of functional associations between HVE-genes.

Authors:  Igor M Dozmorov; James Jarvis; Ricardo Saban; Doris M Benbrook; Edward Wakeland; Ivona Aksentijevich; John Ryan; Nicholas Chiorazzi; Joel M Guthridge; Elizabeth Drewe; Patrick J Tighe; Michael Centola; Ivan Lefkovits
Journal:  Nucleic Acids Res       Date:  2011-06-28       Impact factor: 16.971

2.  Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy".

Authors:  Robert E Hurst; Paul J Hauser; Kimberly D Kyker; Jonathan E Heinlen; Jason P Hodde; Michael C Hiles; Stanley D Kosanke; Mikhail Dozmorov; Michael A Ihnat
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.